A. Lazim, A., A. Lafta, M. (2017). Study the Levels of Glucagon Like Peptide-1(GLP-1) and Related Parameters in Iraqi Hyperlipidemia Patients with Diabetes Mellitus.. , 30(2), 100-111.
Ahmed A. Lazim; Muntaha A. Lafta. "Study the Levels of Glucagon Like Peptide-1(GLP-1) and Related Parameters in Iraqi Hyperlipidemia Patients with Diabetes Mellitus.". , 30, 2, 2017, 100-111.
A. Lazim, A., A. Lafta, M. (2017). 'Study the Levels of Glucagon Like Peptide-1(GLP-1) and Related Parameters in Iraqi Hyperlipidemia Patients with Diabetes Mellitus.', , 30(2), pp. 100-111.
A. Lazim, A., A. Lafta, M. Study the Levels of Glucagon Like Peptide-1(GLP-1) and Related Parameters in Iraqi Hyperlipidemia Patients with Diabetes Mellitus.. , 2017; 30(2): 100-111.

Study the Levels of Glucagon Like Peptide-1(GLP-1) and Related Parameters in Iraqi Hyperlipidemia Patients with Diabetes Mellitus.

Ibn Al-Haitham Journal For Pure And Applied Science
Article 1, Volume 30, Issue 2, 2017, Pages 100-111
Authors
Ahmed A. Lazim; Muntaha A. Lafta
Abstract
The glucagon-like peptide-1 is secreted by intestinal L cells in response to nutrient ingestion. It regulates the secretion and sensitivity of insulin while suppressing glucagon secretion and decreasing postprandial glucose levels , additionally, glucagon-like peptide-1 delays gastric emptying and suppresses appetite. The impaired secretion of glucagon-like peptide-1 has negative influence on hyperlipidemia, diabetes and insulin resistance related diseases the levels of its secretion change with the intake of different nutrients. Some drugs also have influence on GLP-1 secretion .
Keywords
Hyperlipidemia; glucagon like peptide; GLP
Statistics
Article View: 139
PDF Download: 33


Journal Management System. Powered by iJournalPro.com